Search Results - "JELINKOVA, M"

Refine Results
  1. 1

    HPMA copolymers with pH-controlled release of doxorubicin: In vitro cytotoxicity and in vivo antitumor activity by Ulbrich, K, Etrych, T, Chytil, P, Jelı́nková, M, Řı́hová, B

    Published in Journal of controlled release (21-02-2003)
    “…Data on the synthesis, physicochemical characterisation and in vitro and in vivo biological properties of the new, nontargeted or antibody-targeted…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Development of a species‐specific PCR assay for identification of the strictly anaerobic bacterium Selenomonas lacticifex found in biofilm‐covered surfaces in brewery bottling halls by Felsberg, J, Jelínková, M, Kubizniaková, P, Matoulková, D

    Published in Journal of applied microbiology (01-11-2014)
    “…AIMS: In recent years, beer‐spoilage cases from strictly anaerobic bacteria have risen in frequency, in connection with the production of non‐pasteurized,…”
    Get full text
    Journal Article
  3. 3

    Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physico-chemical characterisation by Ulbrich, K, Šubr, V, Strohalm, J, Plocová, D, Jelı́nková, M, Řı́hová, B

    Published in Journal of controlled release (14-02-2000)
    “…This paper describes the synthesis, physico-chemical characteristics and results of selected biological tests of conjugates of antibodies or proteins with…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Statistical analysis of wines using a robust compositional biplot by Hron, K., Jelínková, M., Filzmoser, P., Kreuziger, R., Bednář, P., Barták, P.

    Published in Talanta (Oxford) (15-02-2012)
    “…► Phenolic acids determined in wines by gas chromatography–mass spectrometry. ► Application of centered log-ratio transformation for better data…”
    Get full text
    Journal Article
  5. 5

    Antibody-targeted Polymer-doxorubicin Conjugates with pH-controlled Activation by Ulbrich, K., Etrych, T., Chytil, P., Jelínková, M., íhová, B.

    Published in Journal of drug targeting (01-09-2004)
    “…The paper is dealing with the synthesis and properties of new non-targeted or antibody-targeted polymer drug conjugates, bearing doxorubicin (DOX) attached via…”
    Get full text
    Journal Article
  6. 6

    New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties by Etrych, Tomáš, Jelı́nková, Markéta, Řı́hová, Blanka, Ulbrich, Karel

    Published in Journal of controlled release (18-05-2001)
    “…In this paper we describe the synthesis, physico-chemical characteristics and results of tests of biological activity of polymer drugs based on conjugates of…”
    Get full text
    Journal Article
  7. 7

    Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes by R̆ı́hová, B., Etrych, T., Pechar, M., Jelı́nková, M., Štastný, M., Hovorka, O., Kovář, M., Ulbrich, K.

    Published in Journal of controlled release (06-07-2001)
    “…We have synthesized conjugates containing doxorubicin (DOX) bound to oligopeptide side chains (GlyGly or GlyPheLeuGly) of a water-soluble copolymer carrier…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Polymeric anticancer drugs with pH-controlled activation by Ulbrich, K, Etrych, T, Chytil, P, Pechar, M, Jelinkova, M, Rihova, B

    Published in International journal of pharmaceutics (11-06-2004)
    “…The paper is dealing with the synthesis and properties of new, nontargeted or antibody-targeted pH-sensitive polymer–doxorubicin (DOX) conjugates designed as…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Transcranial sonography of the substantia nigra: digital image analysis by Skoloudík, D, Jelínková, M, Blahuta, J, Cermák, P, Soukup, T, Bártová, P, Langová, K, Herzig, R

    Published in American journal of neuroradiology : AJNR (01-12-2014)
    “…Increased echogenicity of the substantia nigra is a typical transcranial sonography finding in Parkinson disease. Experimental software for digital analysis of…”
    Get full text
    Journal Article
  10. 10

    Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigens by Jelı́nková, M, Strohalm, J, Plocová, D, Šubr, V, Št'astný, M, Ulbrich, K, Řı́hová, B

    Published in Journal of controlled release (31-03-1998)
    “…Binding of HPMA copolymer-conjugated doxorubicin targeted with monoclonal antibodies directed against various T-cell surface receptors, i.e. Thy1.2 (CDw90),…”
    Get full text
    Journal Article
  11. 11

    Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators by Ríhová, B, Jelínková, M, Strohalm, J, Subr, V, Plocová, D, Hovorka, O, Novák, M, Plundrová, D, Germano, Y, Ulbrich, K

    Published in Journal of controlled release (14-02-2000)
    “…We provide data on in vivo targeting of the Thy 1.2 (CDw90) cell surface receptor expressed on neoplastic T cells, mouse EL4 T cell lymphoma. The targeting…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Sequence analysis and heterologous expression of the lincomycin biosynthetic cluster of the type strain Streptomyces lincolnensis ATCC 25466 by Koběrská, M., Kopecký, J., Olšovská, J., Jelínková, M., Ulanova, D., Man, P., Flieger, M., Janata, J.

    Published in Folia microbiologica (01-09-2008)
    “…A cosmid bearing an insert of 38 217 bp covering the gene cluster and its flanking regions of type strain Streptomyces lincolnensis ATCC 25466 was sequenced…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin A by Říhová, B., Strohalm, J., Plocová, D., Šubr, V., Šrogl, J., Jelínková, M., Šírová, M., Ulbrich, K.

    Published in Journal of controlled release (01-07-1996)
    “…Recently we have developed a new generation of antibody-targeted immunosuppressive (cyclosporin A, CyA) and cytostatic (doxorubicin, Dox) drugs effective in…”
    Get full text
    Journal Article
  17. 17

    Influence of mobile phase composition on evaluation of lipophilicity by partition chromatography by Kuchar, M, Kraus, E, Jelínková, M

    Published in Journal of chromatography (20-09-1991)
    “…The problems of the concentration dependence of retention indices and the applicability of extrapolated values in the evaluation of lipophilicity were studied…”
    Get more information
    Journal Article
  18. 18

    Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs by Řı́hová, B, Strohalm, J, Kubáčková, K, Jelı́nková, M, Hovorka, O, Kovář, M, Plocová, D, Šı́rová, M, Št’astný, M, Rozprimová, L, Ulbrich, K

    Published in Journal of controlled release (17-01-2002)
    “…We present data providing new evidence that poly[ N-(2-hydroxypropyl)methacrylamide] (PHPMA)-bound drugs, unlike free drugs, have both cytostatic and…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Cultivation of keratinocytes on poly HEMA and their migration after inversion by Dvoránková, B, Smetana, Jr, K, Vacík, J, Jelínková, M

    Published in Folia biologica (1996)
    “…This study demonstrates how the pretreatment of poly HEMA disks with bovine serum influences the adhesion of human keratinocytes in vitro. The ability of these…”
    Get more information
    Journal Article
  20. 20

    Polymeric drugs based on conjugates of synthetic and natural macromolecules.: II. Anti-cancer activity of antibody or (Fab′) 2-targeted conjugates and combined therapy with immunomodulators by Řı́hová, B, Jelı́nková, M, Strohalm, J, Šubr, V, Plocová, D, Hovorka, O, Novák, M, Plundrová, D, Germano, Y, Ulbrich, K

    Published in Journal of controlled release (14-02-2000)
    “…We provide data on in vivo targeting of the Thy 1.2 (CDw90) cell surface receptor expressed on neoplastic T cells, mouse EL4 T cell lymphoma. The targeting…”
    Get full text
    Journal Article Conference Proceeding